Cargando…

The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials

Omega-3 fatty acids (FA), as a nutrient, has been proven effective in major depressive disorder (MDD), however, the results of monotherapy in perinatal depression (PND) remain unclear. To examine the efficacy and safety of omega-3 fatty acids (FA) monotherapy for perinatal depression (PND) compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mi-Mi, Zou, Yan, Li, Su-Min, Wang, Li, Sun, Yu-Hui, Shi, Le, Lu, Lin, Bao, Yan-Ping, Li, Su-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299975/
https://www.ncbi.nlm.nih.gov/pubmed/32555188
http://dx.doi.org/10.1038/s41398-020-00886-3
_version_ 1783547483980300288
author Zhang, Mi-Mi
Zou, Yan
Li, Su-Min
Wang, Li
Sun, Yu-Hui
Shi, Le
Lu, Lin
Bao, Yan-Ping
Li, Su-Xia
author_facet Zhang, Mi-Mi
Zou, Yan
Li, Su-Min
Wang, Li
Sun, Yu-Hui
Shi, Le
Lu, Lin
Bao, Yan-Ping
Li, Su-Xia
author_sort Zhang, Mi-Mi
collection PubMed
description Omega-3 fatty acids (FA), as a nutrient, has been proven effective in major depressive disorder (MDD), however, the results of monotherapy in perinatal depression (PND) remain unclear. To examine the efficacy and safety of omega-3 fatty acids (FA) monotherapy for perinatal depression (PND) compared with placebo. PubMed, Embase, PsycINFO, MEDLINE, Cochrane Library, and CINAHL were searched from inception up to November 2019. The reference lists of relevant review articles and included studies were also reviewed. Randomized placebo-controlled trials examining the efficacy and safety of omega-3 FA monotherapy in perinatal women with depressive symptoms were included. Pooled standard mean differences (SMD) were calculated and random-effects models were adopted for all analyses. Subgroups analyses and meta-regression were performed to quantify characteristics of the subjects and trials influencing the omega-3 response. In addition, meta-regression was conducted to identify the source of heterogeneity. The study protocol was registered at PROSPERO, CRD42020159542. Eight eligible randomized placebo-controlled trials were included involving 638 participants. There was a significant effect of omega-3 FA on perinatal depression. Omega-3 with higher ratio of EPA/DHA (≥1.5) had significant efficacy both in mild-to-moderate pregnant and postpartum depression with low incidence of side effects. Among the included trials reporting adverse effects, there was no significant difference in incidence of gastrointestinal and neurologic events between the omega-3 and placebo groups. There was no evidence of publication bias. Our findings suggested that omega-3 FA significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum and well-tolerated. Furthermore, the omega-3 response was linked to higher EPA proportion in omega-3 formula and mild- to-moderate depression.
format Online
Article
Text
id pubmed-7299975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72999752020-06-22 The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials Zhang, Mi-Mi Zou, Yan Li, Su-Min Wang, Li Sun, Yu-Hui Shi, Le Lu, Lin Bao, Yan-Ping Li, Su-Xia Transl Psychiatry Article Omega-3 fatty acids (FA), as a nutrient, has been proven effective in major depressive disorder (MDD), however, the results of monotherapy in perinatal depression (PND) remain unclear. To examine the efficacy and safety of omega-3 fatty acids (FA) monotherapy for perinatal depression (PND) compared with placebo. PubMed, Embase, PsycINFO, MEDLINE, Cochrane Library, and CINAHL were searched from inception up to November 2019. The reference lists of relevant review articles and included studies were also reviewed. Randomized placebo-controlled trials examining the efficacy and safety of omega-3 FA monotherapy in perinatal women with depressive symptoms were included. Pooled standard mean differences (SMD) were calculated and random-effects models were adopted for all analyses. Subgroups analyses and meta-regression were performed to quantify characteristics of the subjects and trials influencing the omega-3 response. In addition, meta-regression was conducted to identify the source of heterogeneity. The study protocol was registered at PROSPERO, CRD42020159542. Eight eligible randomized placebo-controlled trials were included involving 638 participants. There was a significant effect of omega-3 FA on perinatal depression. Omega-3 with higher ratio of EPA/DHA (≥1.5) had significant efficacy both in mild-to-moderate pregnant and postpartum depression with low incidence of side effects. Among the included trials reporting adverse effects, there was no significant difference in incidence of gastrointestinal and neurologic events between the omega-3 and placebo groups. There was no evidence of publication bias. Our findings suggested that omega-3 FA significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum and well-tolerated. Furthermore, the omega-3 response was linked to higher EPA proportion in omega-3 formula and mild- to-moderate depression. Nature Publishing Group UK 2020-06-17 /pmc/articles/PMC7299975/ /pubmed/32555188 http://dx.doi.org/10.1038/s41398-020-00886-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Mi-Mi
Zou, Yan
Li, Su-Min
Wang, Li
Sun, Yu-Hui
Shi, Le
Lu, Lin
Bao, Yan-Ping
Li, Su-Xia
The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title_full The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title_fullStr The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title_full_unstemmed The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title_short The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
title_sort efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299975/
https://www.ncbi.nlm.nih.gov/pubmed/32555188
http://dx.doi.org/10.1038/s41398-020-00886-3
work_keys_str_mv AT zhangmimi theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT zouyan theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lisumin theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT wangli theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT sunyuhui theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT shile theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lulin theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT baoyanping theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lisuxia theefficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT zhangmimi efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT zouyan efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lisumin efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT wangli efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT sunyuhui efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT shile efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lulin efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT baoyanping efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials
AT lisuxia efficacyandsafetyofomega3fattyacidsondepressivesymptomsinperinatalwomenametaanalysisofrandomizedplacebocontrolledtrials